TUMOR NECROSIS FACTOR RECEPTOR--STRUCTURE AND FUNCTION
TUMOR NECROSIS FACTOR RECEPTOR--STRUCTURE AND FUNCTION
批准号:
3187540
负责人:
DAVID B DONNER
金额:
$17.5万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-03-01 至 1994-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Tumor necrosis factor (TNF) is a monokine produced by
macrophages in response to invasive stimulation. Tumor necrosis
factor can induce hemorrhagic necrosis and regression of some
tumors in experimental animals and is cytotoxic to tumor cells in
culture. TNF may also be responsible for the wasting (cachexia)
often observed in chronic disease states including cancer.
My goal is to understand how tumor necrosis factor produces its
actions in cells. The initiating step in TNF action is binding to
membrane receptors. Affinity labeling has identified TNF binding
sites in rat liver that are structurally different from those
identified on other cells. It is essential to relate specific cellular
responses to interaction of TNF with its different binding sites on
various target cells. Elucidation of the molecular basis for TNF
action will also require the isolation and purification of the TNF
receptor.
We wish to understand how TNF binding is regulated and
transduced into cellular responses. Binding induces cooperative
interactions among TNF receptors. Also, receptors are
continuously removed from (down-regulation) and added to (up-
regulation) the plasma membrane of target cells. Cooperative
interactions among binding sites and down- and up-regulation of
the TNF receptor will be characterized and related to changes of
cellular responsiveness to TNF. Coupling of cytokine-receptor
complexes to the membrane cytoskeleton and changes in the
phosphorylation state of specific target proteins are two
mechanisms through which binding is transduced into biologic
actions. The role of these events in TNF action will be
characterized.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Interaction of the human insulin receptor tyrosine kinase from the baculovirus expression system with protein kinase C in a cell-free system.
杆状病毒表达系统中的人胰岛素受体酪氨酸激酶与无细胞系统中蛋白激酶 C 的相互作用。
DOI:
--
发表时间:
1993
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Ahn,J, Donner,DB, Rosen,OM]
通讯作者:
Rosen,OM
Acute metabolic effects of human recombinant tumor necrosis factor beta in the rat.
人重组肿瘤坏死因子β对大鼠的急性代谢作用。
DOI:
10.1007/bf02303808
发表时间:
1994
期刊:
Annals of surgical oncology
影响因子:
3.7
作者:
[Blumberg,D, Tsuburaya,A, Burt,M, Donner,DB, Brennan,MF]
通讯作者:
Brennan,MF
Human insulin receptor mutated at threonine 1336 functions normally in Chinese hamster ovary cells.
苏氨酸 1336 处突变的人胰岛素受体在中国仓鼠卵巢细胞中功能正常。
DOI:
--
发表时间:
1993
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Ahn,J, Rosen,OM, Donner,DB]
通讯作者:
Donner,DB
Phosphorylation of the proto-oncogene product eukaryotic initiation factor 4E is a common cellular response to tumor necrosis factor.
原癌基因产物真核起始因子4E的磷酸化是对肿瘤坏死因子的常见细胞反应。
DOI:
--
发表时间:
1991
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Marino,MW, Feld,LJ, Jaffe,EA, Pfeffer,LM, Han,HM, Donner,DB]
通讯作者:
Donner,DB
Identification, characterization, and homologous up-regulation of latent (cryptic) receptors for tumor necrosis factor-alpha in rat liver plasma membranes.
大鼠肝质膜中肿瘤坏死因子-α 潜在(隐性)受体的鉴定、表征和同源上调。
DOI:
--
发表时间:
1990
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Han,HM, Kolhatkar,AA, Marino,MW, Manchester,KM, Donner,DB]
通讯作者:
Donner,DB
共 9 条
Tumor Necrosis Factor Action in Cells
-
批准号:6431147
-
项目类别:
-
资助金额:$33.53万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
TTUMOR NECROSIS FACTOR ACTION IN CELLS
-
批准号:2871867
-
项目类别:
-
资助金额:$23.48万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
VASCULAR ENDOTHELIAL CELL GROWTH FACTOR IN PATHOLOGY
-
批准号:2895807
-
项目类别:
-
资助金额:$23.03万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
Tumor Necrosis Factor Action in Cells
-
批准号:6712832
-
项目类别:
-
资助金额:$33.53万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
TTUMOR NECROSIS FACTOR ACTION IN CELLS
-
批准号:2654194
-
项目类别:
-
资助金额:$22.8万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
Tumor Necrosis Factor Action in Cells
-
批准号:6865820
-
项目类别:
-
资助金额:$33.53万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
VASCULAR ENDOTHELIAL CELL GROWTH FACTOR IN PATHOLOGY
-
批准号:6376345
-
项目类别:
-
资助金额:$24.43万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
Tumor Necrosis Factor Action in Cells
-
批准号:6621236
-
项目类别:
-
资助金额:$33.53万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
TTUMOR NECROSIS FACTOR ACTION IN CELLS
-
批准号:2008907
-
项目类别:
-
资助金额:$22.14万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
VASCULAR ENDOTHELIAL CELL GROWTH FACTOR IN PATHOLOGY
-
批准号:6172863
-
项目类别:
-
资助金额:$23.72万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
TTUMOR NECROSIS FACTOR ACTION IN CELLS
-
批准号:6150202
-
项目类别:
-
资助金额:$24.19万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
VASCULAR ENDOTHELIAL CELL GROWTH FACTOR IN PATHOLOGY
-
批准号:2733318
-
项目类别:
-
资助金额:$22.36万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
TTUMOR NECROSIS FACTOR ACTION IN CELLS
-
批准号:6350179
-
项目类别:
-
资助金额:$24.91万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
Tumor Necrosis Factor Action in Cells
-
批准号:7022278
-
项目类别:
-
资助金额:$33.62万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
VASCULAR ENDOTHELIAL CELL GROWTH FACTOR IN PATHOLOGY
-
批准号:2386930
-
项目类别:
-
资助金额:$21.7万
-
财政年份:1997
-
负责人:DAVID B DONNER
-
依托单位:
TUMOR NECROSIS FACTOR ACTION IN CELLS
-
批准号:2111693
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:DAVID B DONNER
-
依托单位:
TUMOR NECROSIS FACTOR RECEPTOR: STRUCTURE AND FUNCTION
-
批准号:3187536
-
项目类别:
-
资助金额:$19.92万
-
财政年份:1988
-
负责人:DAVID B DONNER
-
依托单位:
TUMOR NECROSIS FACTOR RECEPTOR: STRUCTURE AND FUNCTION
-
批准号:3187538
-
项目类别:
-
资助金额:$21.86万
-
财政年份:1988
-
负责人:DAVID B DONNER
-
依托单位:
TUMOR NECROSIS FACTOR RECEPTOR: STRUCTURE AND FUNCTION
-
批准号:3187537
-
项目类别:
-
资助金额:$21.14万
-
财政年份:1988
-
负责人:DAVID B DONNER
-
依托单位:
TUMOR NECROSIS FACTOR RECEPTOR: STRUCTURE AND FUNCTION
-
批准号:3187533
-
项目类别:
-
资助金额:$18.68万
-
财政年份:1988
-
负责人:DAVID B DONNER
-
依托单位:
海外基金